Details of the Drug

General Information of Drug (ID: DMGUHYW)

• Drug Name: NI-0501
• Synonyms: Anti-IFN gamma antibody, NovImmune/Merck Serono; Anti-IFN gamma antibody, NovImmune/Serono; Anti-interferon gamma antibody, NovImmune/Merck Serono; Anti-interferon gamma antibody, NovImmune/Serono

Indication

Disease Entry	ICD 11	Status	REF
Autoimmune diabetes	5A10	Phase 2	[1]
Primary haemophagocytic lymphohistiocytosis	4A01.23	Phase 2	[2]

• Cross-matching ID: TTD ID: D0QV4A
• Repurposed Drugs (RPD): Click to Jump to the Detailed RPD Information of This Drug

References

• [1] ClinicalTrials.gov (NCT01818492) A Study to Investigate the Safety and Efficacy of an Anti-IFN mAb in Children Affected by Primary Haemophagocytic Lymphohistiocytosis. U.S. National Institutes of Health.
• [2] Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)